Patent · US Active

Metastin derivatives and use thereof

US8361968B2 · kind B2 · utility

2Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2011
Grant dateJan 29, 2013
Priority date
Expiry dateJun 29, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a metastin derivative in which the amino acids comprising metastin were modified by alternative chemical substituents resulting in metastin derivitives, having excellent blood stability and exhibiting cancer metastasis inhibiting action or cancer growth inhibiting action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.